Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification Article Swipe
Alison Meynert
,
Tzyvia Rye
,
Ian Croy
,
Alistair Williams
,
Aikou Okamoto
,
J. Carl Barrett
,
Athena Matakidou
,
D. Paul Harkin
,
Richard D. Kennedy
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30705575
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.30705575
Tumor-infiltrating immune cells across high-grade serous carcinoma subtypes. A, CD3+ infiltration across HRR-centric subtypes; labeled P value represents comparison of BRCA2m and CCNE1g groups using the Mann–Whitney U test. B, CD3+ infiltration across TCGA transcriptomic subtypes; labeled P value represents comparison of IMR and PRO groups using the Mann–Whitney U test. C, CD3+ infiltration across Tothill transcriptomic subtypes; labeled P value represents comparison of C2 and C5 groups using the Mann–Whitney U test. BRCA2m, BRCA2 mutant; BRCA1m, BRCA1 mutant; EMSY-overxp; overexpression of EMSY; CCNE1g, gain of CCNE1; HRRwt, non-CCNE1g HRR wild-type.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Landing Page
- https://doi.org/10.1158/1078-0432.30705575
- OA Status
- gold
- OpenAlex ID
- https://openalex.org/W4416672402
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416672402Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.30705575Digital Object Identifier
- Title
-
Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient StratificationWork title
- Type
-
articleOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-25Full publication date if available
- Authors
-
Alison Meynert, Tzyvia Rye, Ian Croy, Alistair Williams, Aikou Okamoto, J. Carl Barrett, Athena Matakidou, D. Paul Harkin, Richard D. KennedyList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.30705575Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.30705575Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4416672402 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.30705575 |
| ids.doi | https://doi.org/10.1158/1078-0432.30705575 |
| ids.openalex | https://openalex.org/W4416672402 |
| fwci | 0.0 |
| type | article |
| title | Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | |
| locations[0].id | doi:10.1158/1078-0432.30705575 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.30705575 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5080389454 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5839-1751 |
| authorships[0].author.display_name | Alison Meynert |
| authorships[0].author_position | middle |
| authorships[0].raw_author_name | Alison M. Meynert |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5072257828 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Tzyvia Rye |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Tzyvia Rye |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5062477386 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Ian Croy |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ian Croy |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5019395613 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7085-4525 |
| authorships[3].author.display_name | Alistair Williams |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Alistair R.W. Williams |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5063042904 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5079-0464 |
| authorships[4].author.display_name | Aikou Okamoto |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Aikou Okamoto |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5032813114 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6028-3976 |
| authorships[5].author.display_name | J. Carl Barrett |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | J. Carl Barrett |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5045493603 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8656-3802 |
| authorships[6].author.display_name | Athena Matakidou |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Athena Matakidou |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5087259821 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | D. Paul Harkin |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | D. Paul Harkin |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5088266020 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4737-6163 |
| authorships[8].author.display_name | Richard D. Kennedy |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Richard Kennedy |
| authorships[8].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.30705575 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-25T00:00:00 |
| display_name | Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T20:18:07.440809 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.30705575 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.30705575 |
| primary_location.id | doi:10.1158/1078-0432.30705575 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.30705575 |
| publication_date | 2025-11-25 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.C2 | 64 |
| abstract_inverted_index.C5 | 66 |
| abstract_inverted_index.of | 19, 41, 63, 81, 85 |
| abstract_inverted_index.HRR | 89 |
| abstract_inverted_index.IMR | 42 |
| abstract_inverted_index.PRO | 44 |
| abstract_inverted_index.and | 21, 43, 65 |
| abstract_inverted_index.the | 25, 47, 69 |
| abstract_inverted_index.TCGA | 33 |
| abstract_inverted_index.gain | 84 |
| abstract_inverted_index.cells | 2 |
| abstract_inverted_index.test. | 28, 50, 72 |
| abstract_inverted_index.using | 24, 46, 68 |
| abstract_inverted_index.value | 16, 38, 60 |
| abstract_inverted_index.HRRwt, | 87 |
| abstract_inverted_index.across | 3, 11, 32, 54 |
| abstract_inverted_index.groups | 23, 45, 67 |
| abstract_inverted_index.immune | 1 |
| abstract_inverted_index.serous | 5 |
| abstract_inverted_index.Tothill | 55 |
| abstract_inverted_index.labeled | 14, 36, 58 |
| abstract_inverted_index.mutant; | 75, 78 |
| abstract_inverted_index.carcinoma | 6 |
| abstract_inverted_index.subtypes. | 7 |
| abstract_inverted_index.subtypes; | 13, 35, 57 |
| abstract_inverted_index.comparison | 18, 40, 62 |
| abstract_inverted_index.high-grade | 4 |
| abstract_inverted_index.represents | 17, 39, 61 |
| abstract_inverted_index.HRR-centric | 12 |
| abstract_inverted_index.infiltration | 10, 31, 53 |
| abstract_inverted_index.Mann–Whitney | 26, 48, 70 |
| abstract_inverted_index.overexpression | 80 |
| abstract_inverted_index.transcriptomic | 34, 56 |
| abstract_inverted_index.<i>P</i> | 15, 37, 59 |
| abstract_inverted_index.<i>U</i> | 27, 49, 71 |
| abstract_inverted_index.wild-type.</p> | 90 |
| abstract_inverted_index.<b>A,</b> | 8 |
| abstract_inverted_index.<b>B,</b> | 29 |
| abstract_inverted_index.<b>C,</b> | 51 |
| abstract_inverted_index.<i>BRCA1</i> | 77 |
| abstract_inverted_index.<i>BRCA2</i> | 74 |
| abstract_inverted_index.<i>EMSY</i>; | 82 |
| abstract_inverted_index.<i>BRCA2</i>m | 20 |
| abstract_inverted_index.<i>CCNE1</i>; | 86 |
| abstract_inverted_index.<i>CCNE1</i>g | 22 |
| abstract_inverted_index.<i>BRCA1</i>m, | 76 |
| abstract_inverted_index.<i>BRCA2</i>m, | 73 |
| abstract_inverted_index.<i>CCNE1</i>g, | 83 |
| abstract_inverted_index.<p>Tumor-infiltrating | 0 |
| abstract_inverted_index.CD3<sup>+</sup> | 9, 30, 52 |
| abstract_inverted_index.non-<i>CCNE1</i>g | 88 |
| abstract_inverted_index.<i>EMSY</i>-overxp; | 79 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile |